Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam vs Levetiracetam in Pediatric Epilepsy
NCT07163585Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Aug 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of brivaracetam in epilepsy (2 arms), sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Cessation of seizures at 3 months. Started Aug 2024; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07163585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07163585.